Polycystic Ovary SyndromeMetforminOvaryHyperandrogenismPolycystic Kidney DiseasesHirsutismPolycystic Kidney, Autosomal DominantOligomenorrheaAnovulationHypoglycemic AgentsClomipheneInfertility, FemaleFertility Agents, FemaleTestosteroneInsulin ResistanceAndrogensAndrostenedioneTRPP Cation ChannelsPolycystic Kidney, Autosomal RecessiveLuteinizing Hormone17-alpha-HydroxyprogesteroneOvulation InductionMenstruation DisturbancesFollicle Stimulating HormoneDehydroepiandrosterone SulfatePregnancyCyproterone AcetateOvulationInsulinWomenAnti-Mullerian HormoneWomen's HealthBody Mass IndexSex Hormone-Binding GlobulinObesityAcne VulgarisBlood GlucoseOvarian FollicleMenstrual CycleAmenorrheaCase-Control StudiesCystsThiazolidinedionesDiabetes Mellitus, Type 2Glucose Tolerance TestHormonesGonadotropinsEthinyl EstradiolEstradiolHyperinsulinismPregnancy RateOvarian DiseasesElectrocoagulationMenstruationDehydroepiandrosteroneVirilismFertilization in VitroOvarian CystsTheca CellsOvarian Hyperstimulation SyndromeLive BirthDiathermySteroid 17-alpha-HydroxylaseRisk FactorsMenstruation-Inducing AgentsSulfonylurea CompoundsCohort StudiesFollicle Stimulating Hormone, HumanPregnancy OutcomeProgesteroneTreatment OutcomeAMP-Activated Protein KinasesGonadal Steroid HormonesDiabetes, GestationalSteroidsElectroacupunctureCross-Sectional StudiesInfertilityGranulosa CellsGonadotropin-Releasing HormoneFollicular FluidBiological MarkersGlucose IntoleranceFollicular PhaseBody WeightAcanthosis NigricansDrug Therapy, CombinationChorionic GonadotropinReproductive Techniques, AssistedPhenforminPlacebosPregnant WomenBattered WomenAge FactorsOverweightReference ValuesReceptors, FSHMetabolic Syndrome XDouble-Blind MethodPhenotype